Any organic heterobicyclic compound consisting of a benzene ring fused to a thiopyran.
ChEBI ID: 50747
Member | Definition | Role |
---|---|---|
2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide | 2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide | |
agn 190299 | A thiochromane that is acetylene in which the hydrogens are replaced by 5-carboxypyridin-2-yl and 4,4-dimethylthiochroman-6-yl groups. It is the active form of the prodrug tazarotene. | tazarotenic acid |
Meticrane | Meticrane | |
ro 41-5253 | A thiochromane that is 3,4-dihydro-2H-1-benzothiopyran S,S-dioxide in which the hydrogens at position 4 are both replaced by methyl groups, the hydrogens at position 7 is replaced by a heptyloxy group, while the hydrogen at position 6 is replaced by a 1-phenylprop-1-en-2-yl group, the phenyl group of which is substituted at the para position by a carboxy group. It is a selective antagonist for retinoic acid receptor alpha. | Ro 41-5253 |
tazarotene | The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin. | tazarotene |
tertatolol | tertatolol |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 68 (11.33) | 18.7374 |
1990's | 148 (24.67) | 18.2507 |
2000's | 186 (31.00) | 29.6817 |
2010's | 125 (20.83) | 24.3611 |
2020's | 73 (12.17) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 160 (24.02%) | 5.53% |
Reviews | 105 (15.77%) | 6.00% |
Case Studies | 70 (10.51%) | 4.05% |
Observational | 1 (0.15%) | 0.25% |
Other | 330 (49.55%) | 84.16% |